Table 4 |
|||||
| Distribution of IHC markers in tumors | |||||
| Total (n=500) | BLBC (n=47) | NBBC (n=453) | BLBC versus NBBC | ||
| p value | Odds ratio (95% CI) | ||||
| CK 5/6 | 257 (51%) | 45 (95.7%) | 212 (46.8%) | ||
| EGFR | 75 (15%) | 25 (51.3%) | 50 (11%) | ||
| CK 14 | 48 (9.6%) | 13 (27.7%) | 35 (7.7%) | p<0.0001 | 4.56 (2.20-9.44) |
| Vimentin | 68 (13.6%) | 25 (53.2%) | 43 (9.5%) | p<0.0001 | 10.83 (5.63-20.82) |
Cakir et al. Diagnostic Pathology 2012 7:145 doi:10.1186/1746-1596-7-145
